1. Home
  2. OMF vs CYTK Comparison

OMF vs CYTK Comparison

Compare OMF & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

N/A

Current Price

$52.60

Market Cap

8.3B

Sector

Finance

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$59.89

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OMF
CYTK
Founded
1920
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.6B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
OMF
CYTK
Price
$52.60
$59.89
Analyst Decision
Buy
Strong Buy
Analyst Count
12
18
Target Price
$69.17
$87.56
AVG Volume (30 Days)
1.5M
1.7M
Earning Date
05-07-2026
05-25-2026
Dividend Yield
7.81%
N/A
EPS Growth
54.72
N/A
EPS
6.56
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$71.78
$9.79
Revenue Next Year
$6.89
$302.66
P/E Ratio
$8.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.00
$29.31
52 Week High
$71.93
$70.98

Technical Indicators

Market Signals
Indicator
OMF
CYTK
Relative Strength Index (RSI) 30.89 40.30
Support Level $51.93 $59.25
Resistance Level $53.52 $65.93
Average True Range (ATR) 1.77 2.65
MACD 0.05 -0.32
Stochastic Oscillator 15.79 3.98

Price Performance

Historical Comparison
OMF
CYTK

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: